China Pharma Holdings (CPHI) FCF Margin Growth (5y) (2015 - 2026)
China Pharma Holdings (CPHI) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | China Pharma Holdings | 41.74 Mn | 41.43 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 612.00 |
| Dec 31, 2025 | -700.00 |
| Sep 30, 2025 | -1,127.00 |
| Jun 30, 2025 | 4,057.00 |
| Mar 31, 2025 | 2,194.00 |
| Dec 31, 2024 | 2,700.00 |
| Sep 30, 2024 | -2,312.00 |
| Jun 30, 2024 | -2,292.00 |
| Mar 31, 2024 | -3,212.00 |
| Dec 31, 2023 | -2,766.00 |
| Sep 30, 2023 | 1,383.00 |
| Jun 30, 2023 | -589.00 |
| Mar 31, 2023 | -8,643.00 |
| Dec 31, 2022 | -160.00 |
| Sep 30, 2022 | -2,265.00 |
| Jun 30, 2022 | -384.00 |
| Mar 31, 2022 | -5,440.00 |
| Dec 31, 2021 | -3,308.00 |
| Sep 30, 2021 | -7,090.00 |
| Jun 30, 2021 | 5,209.00 |